Therapeutics

Strategic Buyers

Ayala Pharmaceuticals Merges with Biosight

The combined company will operate under the name Ayala Pharmaceuticals Inc.

July 27, 2023

SPACs

Starton Combines with Healthwell

Starton looks to improve the efficacy of approved drugs, make them more tolerable and expand their use.

April 27, 2023

Private Equity

Arlington Forms AVS Bio

AVS Bio supplies manufacturers with bioprocessing inputs including SPF eggs, antigens and cell products.

January 5, 2023

Private Equity

LongueVue Capital Makes Investment in Pinnacle

Pinnacle Clinical Research operates clinical trial sites across Texas with a focus on hepatology and non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

November 16, 2022

Private Equity

Why J.P. Morgan is Diving into Life Sciences

Attractive valuations and the rapid pace of biomedical innovation make it an ideal time for the investment bank to seek deals in the space.

November 10, 2022

Private Equity

J.P. Morgan Launches Life Sciences Private Capital

The new team will invest in early and growth-stage healthcare companies aligned to specific market opportunities with a focus on novel therapeutics and technologies.

November 2, 2022

Private Equity